Personal profile
Research interests
Dr. Megan Jones’ research interests involved understanding the interplay of autophagy (a highly conserved cellular recycling pathway) and apoptosis (a highly conserved regulated cell death pathway) for cancer therapy. Her early work characterized a novel cell death pathway in which stalled autophagy initiates caspase-8-dependent apoptosis. Dr. Jones’ research expanded to seek an understanding of how bioactive sphingolipids regulate intracellular membrane trafficking for autophagy and cancer cell death.
Dr. Jones is the Assistant Director of Research Development. In this role, she brings along skills in proposal writing and grantsmanship and an interest in connecting others with resources to strengthen their research programs. Her responsibilities include managing the internal grant programs, assisting in the Pure project implementation at the College of Medicine, and serving as a liaison to Penn State InfoReady for the College of Medicine.
Education/Academic qualification
Postdoctoral Scholar, Penn State College of Medicine
… → Jul 2019
Pharmacology, PhD, The Role of Sphingosine Kinase in the Crosstalk between Apoptosis, Autophagy and Endocytosis, Penn State College of Medicine
… → Oct 2015
Business Administration, MBA, Penn State Harrisburg
… → 2014
Chemistry, BS, Bucknell University
… → 2008
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Research networking and the role of the medical librarian
Reed, R., Eyer, M. J., Jones, M. & Bronson, S. K., Apr 2024, In: Journal of the Medical Library Association. 112, 2, p. 153-157 5 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
Liu, X., Wills, C. A., Chen, L., Zhang, J., Zhao, Y., Zhou, M., Sundstrom, J. M., Schell, T., Spiegelman, V. S., Young, M. M. & Wang, H. G., Apr 28 2022, In: Journal for ImmunoTherapy of Cancer. 10, 4, e004399.Research output: Contribution to journal › Article › peer-review
Open Access44 Link opens in a new tab Scopus citations -
Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia
Gebru, M. T., Atkinson, J. M., Young, M. M., Zhang, L., Tang, Z., Liu, Z., Lu, P., Dower, C. M., Chen, L., Annageldiyev, C., Sharma, A., Kawasawa, Y. I., Zhao, Z., Miller, B. A., Claxton, D. F. & Wang, H. G., Aug 27 2020, In: Blood. 136, 9, p. 1067-1079 13 p.Research output: Contribution to journal › Article › peer-review
Open Access30 Link opens in a new tab Scopus citations -
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression
Yee, P. P., Wei, Y., Kim, S. Y., Lu, T., Chih, S. Y., Lawson, C., Tang, M., Liu, Z., Anderson, B., Thamburaj, K., Young, M. M., Aregawi, D. G., Glantz, M. J., Zacharia, B. E., Specht, C. S., Wang, H. G. & Li, W., Dec 1 2020, In: Nature communications. 11, 1, 5424.Research output: Contribution to journal › Article › peer-review
Open Access356 Link opens in a new tab Scopus citations -
FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia
Young, M. M., Bui, V., Chen, C. & Wang, H. G., Nov 1 2019, In: Cell Death and Disease. 10, 11, 847.Research output: Contribution to journal › Article › peer-review
Open Access31 Link opens in a new tab Scopus citations